Rapid diagnostics for SARS-CoV-2 virus: point-of-care testing and lessons learned during the pandemic Comment

Trieu Nguyen*, Anders Wolff

*Corresponding author for this work

Research output: Contribution to journalJournal articleResearchpeer-review

Abstract

The COVID-19 pandemic originated from an outbreak of novel coronavirus in Wuhan City, in the Hubei Provence of China, in late 2019. The virus was later named severe acute respiratory syndrome-related coronavirus 2, or SARS-CoV-2, in February 2020. More than a year into the pandemic (at the time we write this article in May 2021), the world is still struggling with testing, isolating clusters, curfews and lockdowns as there is a lack of an efficient antiviral for SARS-CoV-2 and the distribution of COVID-19 vaccines is still a work in progress. The pandemic is currently in it's third wave. This commentary article focuses on early, onsite and rapid detection, such as point-of-care (POC) diagnostics of SARS-Cov-2. POC serology tests, namely antibodies-related tests are not discussed in this viewpoint as they are not applicable for early detection of SARS-Cov-2 due to the antibody's long-overdue presentation response (whic can commence at 2 weeks or later) int the majority of cases after exhibiting symptoms.
Original languageEnglish
JournalBioanalysis
Volume13
Issue number15
Pages (from-to)1165-1167
Number of pages4
ISSN1757-6180
DOIs
Publication statusPublished - 2021

Keywords

  • Coronavirus
  • COVID-19
  • In vitro diagnostic regulation
  • Lessons
  • Nucleic amplification
  • Pandemic
  • Point-of-care testing
  • Rapid diagnostics
  • Reverse-transcription polymerase chain reaction
  • SARS-CoV-2

Fingerprint

Dive into the research topics of 'Rapid diagnostics for SARS-CoV-2 virus: point-of-care testing and lessons learned during the pandemic Comment'. Together they form a unique fingerprint.

Cite this